Steroid Dependent Acute GvHD: An Interprofessional Approach

Program Overview

Acute graft-versus-host disease (aGvHD) is a common complication of allogenic hematopoietic stem cell transplant (allo-HSCT). Corticosteroids, usually at high doses, comprise the mainstay of first-line treatment for most patients, but can often be intolerable due to adverse events and the development of steroid-dependent disease. In this activity, an interprofessional expert panel discusses a physician-submitted case of a 45-year-old man who developed steroid-dependent aGvHD after undergoing an allo-HSCT for high-risk acute myelogenous leukemia (AML). The panel will provide insight and input from a medical, pharmacy, and PA perspective.

Credit Expired

Target Audience

Hematology, hematology/oncology, transplantation clinicians

Educational Objectives

Upon completion of this activity, participants should be better able to:

  • Integrate the unique roles and responsibilities of interprofessional care team members when managing hematopoietic stem cell transplant (HSCT) recipients with acute graft-versus-host disease (aGvHD)

Activity Faculty

136-24-1347-VL-001 Faculty Headshot-RGB-Kitko

Carrie L. Kitko, MD  

Associate Professor, Pediatrics and Hematology/Oncology
Ingram Professorship, Pediatric Oncology, Department of Pediatrics
Medical Director, Pediatric Stem Cell Transplantation Program
Vanderbilt University Medical Center
Nashville, TN

136-24-1347-VL-001 Faculty Headshot-RGB-KGatwood

Katie S. Gatwood, PharmD, BCOP

Clinical Pharmacist Specialist, Stem Cell Transplant & Cellular Therapy
Vanderbilt University Medical Center
Nashville, TN

136-24-1347-VL-001 Faculty Headshot-RGB-Yennaco

Christine Yennaco, PA-C, MPH, MCHS

Associate Director, Advanced Practice Providers – BMT & Immunotherapy
Fred Hutchinson Cancer Center
Teaching Associate, UW Medicine
University of Washington
Seattle, WA

Subscribe

Stay up to date with the latest RMEI CE Activities and receive Exclusive Medical Education Resources